|
1.
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Portolani N, Coniglio A, Ghidoni S,
Giovanelli M, Benetti A, Tiberio GA and Giulini SM: Early and late
recurrence after liver resection for hepatocellular carcinoma:
Prognostic and therapeutic implications. Ann Surg. 243:229–235.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Yang Y, Nagano H, Ota H, Morimoto O,
Nakamura M, Wada H, Noda T, Damdinsuren B, Marubashi S, Miyamoto A,
et al: Patterns and clinicopathologic features of extrahepatic
recurrence of hepatocellular carcinoma after curative resection.
Surgery. 141:196–202. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Llovet JM, Ricci S, Mazzaferro V, Hilgard
P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A,
et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J
Med. 359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S,
Kim JS, Luo R, Feng J, Ye S, Yang TS, et al: Efficacy and safety of
sorafenib in patients in the Asia-Pacific region with advanced
hepatocellular carcinoma: A phase III randomised, double-blind,
placebo-controlled trial. Lancet Oncol. 10:25–34. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Bruix J and Sherman M: American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kudo M, Izumi N, Kokudo N, Matsui O,
Sakamoto M, Nakashima O, Kojiro M and Makuuchi M: HCC Expert Panel
of Japan Society of Hepatology: Management of hepatocellular
carcinoma in Japan: Consensus-based clinical practice guidelines
proposed by the Japan Society of Hepatology (JSH) 2010 updated
version. Dig Dis. 29:339–364. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Forrest LM, McMillan DC, McArdle CS,
Angerson WJ and Dunlop DJ: Evaluation of cumulative prognostic
scores based on the systemic inflammatory response in patients with
inoperable non-small-cell lung cancer. Br J Cancer. 89:1028–1030.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Gomez D, Farid S, Malik HZ, Young AL,
Toogood GJ, Lodge JP and Prasad KR: Preoperative
neutrophil-to-lymphocyte ratio as a prognostic predictor after
curative resection for hepatocellular carcinoma. World J Surg.
32:1757–1762. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Huang ZL, Luo J, Chen MS, Li JQ and Shi M:
Blood neutrophil-to-lymphocyte ratio predicts survival in patients
with unresectable hepatocellular carcinoma undergoing transarterial
chemoembolization. J Vasc Interv Radiol. 22:702–709. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Halazun KJ, Hardy MA, Rana AA, Woodland DC
IV, Luyten EJ, Mahadev S, Witkowski P, Siegel AB, Brown RS Jr and
Emond JC: Negative impact of neutrophil-lymphocyte ratio on outcome
after liver transplantation for hepatocellular carcinoma. Ann Surg.
250:141–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Bertuzzo VR, Cescon M, Ravaioli M, Grazi
GL, Ercolani G, Del Gaudio M, Cucchetti A, D'Errico-Grigioni A,
Golfieri R and Pinna AD: Analysis of factors affecting recurrence
of hepatocellular carcinoma after liver transplantation with a
special focus on inflammation markers. Transplantation.
91:1279–1285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Dan J, Zhang Y, Peng Z, Huang J, Gao H, Xu
L and Chen M: Postoperative neutrophil-to-lymphocyte ratio change
predicts survival of patients with small hepatocellular carcinoma
undergoing radiofrequency ablation. PLoS One. 8:e581842013.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Trinchieri G: Cancer and inflammation: an
old intuition with rapidly evolving new concepts. Annu Rev Immunol.
30:677–706. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Pawlik TM, Esnaola NF and Vauthey JN:
Surgical treatment of hepatocellular carcinoma: Similar long-term
results despite geographic variations. Liver Transpl. 10(2 Suppl
1): S74–S80. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Yoo DJ, Kim KM, Jin YJ, Shim JH, Ko GY,
Yoon HK, Sung KB, Lee JL, Kang YK, Lim YS, et al: Clinical outcome
of 251 patients with extrahepatic metastasis at initial diagnosis
of HCC: Does transarterial chemoembolization improve survival in
these patients? J Gastroentel Hepatol. 26:145–154. 2011. View Article : Google Scholar
|
|
18.
|
Katyal S, Oliver JH III, Peterson MS,
Ferris JV, Carr BS and Baron RL: Extrahepatic metastases of
hepatocellular carcinoma. Radiology. 216:698–703. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Uka K, Aikata H, Takaki S, Shirakawa H,
Jeong SC, Yamashina K, Hiramatsu A, Kodama H, Takahashi S and
Chayama K: Clinical features and prognosis of patients with
extrahepatic metastases from hepatocellular carcinoma. World J
Gastroenterol. 13:414–420. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Uchino K, Tateishi R, Shiina S, Kanda M,
Masuzaki R, Kondo Y, Goto T, Omata M, Yoshida H and Koike K:
Hepatocellular carcinoma with extrahepatic metastasis: Clinical
features and prognostic factors. Cancer. 117:4475–4483. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Ishii H, Furuse J, Kinoshita T, Konishi M,
Nakagohri T, Takahashi S, Gotohda N, Nakachi K and Yoshino M:
Extrahepatic spread from HCC: Who are candidates for aggressive
anti-cancer treatment? Jpn J Clin Oncolol. 34:733–739. 2004.
View Article : Google Scholar
|
|
22.
|
Natsuizaka M, Omura T, Akaike T, Kuwata Y,
Yamazaki K, Sato T, Karino Y, Toyota J, Suga T and Asaka M:
Clinical features of hepatocellular carcinoma with extrahepatic
metastases. J Gastroenterol Hepatol. 20:1781–1787. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Yoo DJ, Kim KM, Jin YJ, Shim JH, Ko GY,
Yoon HK, Sung KB, Lee JL, Kang YK, Lim YS, et al: Clinical outcome
of 251 patients with extrahepatic metastasis at initial diagnosis
of hepatocellular carcinoma: Does transarterial chemoembolization
improve survival in these patients? J Gastroenterol Hepatol.
26:145–154. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Pawarode A, Voravud N, Sriuranpong V,
Kullavanijaya P and Patt YZ: Natural history of untreated primary
HCC: A retrospective study of 157 patients. Am J Clin Oncol.
21:386–391. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Ding PR, An X, Zhang RX, Fang YJ, Li LR,
Chen G, Wu XJ, Lu ZH, Lin JZ, Kong LH, et al: Elevated preoperative
neutrophil to lymphocyte ratio predicts risk of recurrence
following curative resection for stage IIA colon cancer. Int J
Colorectal Dis. 25:1427–1433. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Jung MR, Park YK, Jeong O, Seon JW, Ryu
SY, Kim DY and Kim YJ: Elevated preoperative neutrophil to
lymphocyte ratio predicts poor survival following resection in late
stage gastric cancer. J Surg Oncol. 104:504–510. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Stotz M, Gerger A, Eisner F, Szkandera J,
Loibner H, Ress AL, Kornprat P, AlZoughbi W, Seggewies FS, Lackner
C, et al: Increased neutrophil-lymphocyte ratio is a poor
prognostic factor in patients with primary operable and inoperable
pancreatic cancer. Br J Cancer. 109:416–321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Xiao WK, Chen D, Li SQ, Fu SJ, Peng BG and
Liang LJ: Prognostic significance of neutrophil-lymphocyte ratio in
hepatocellular carcinoma: A meta-analysis. BMC Cancer. 14:1172014.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Coussens LM, Tinkle CL, Hanahan D and Werb
Z: MMP-9 supplied by bone marrow-derived cells contributes to skin
carcinogenesis. Cell. 103:481–490. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Strieter RM, Burdick MD, Mestas J,
Gomperts B, Keane MP and Belperio JA: Cancer CXC chemokine networks
and tumour angiogenesis. Eur J Cancer. 42:768–778. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Gong Y and Koh DR: Neutrophils promote
inflammatory angiogenesis via release of preformed VEGF in an in
vivo corneal model. Cell Tissue Res. 339:437–448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Chew V, Tow C, Teo M, Wong HL, Chan J,
Gehring A, Loh M, Bolze A, Quek R, Lee VK, et al: Inflammatory
tumour microenvironment is associated with superior survival in
hepatocellular carcinoma patients. J Hepatol. 52:370–379. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
McMillan DC: The systemic
inflammation-based Glasgow prognostic score: A decade of experience
in patients with cancer. Cancer Treat Rev. 39:534–540. 2013.
View Article : Google Scholar : PubMed/NCBI
|
